Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jan 2008 for MGI PHARMA INC, €168k.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David B. Sharrock: trading record in brief
This profile gathers the share dealings of David B. Sharrock across 2 companies, led by MGI Pharma Inc and Praecis Pharmaceuticals Inc. The record holds 4 filings, for trades running from 8 August 2006 to 23 January 2008.
No open-market sale appears; the market trades are 2 purchases worth €43k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 24 January 2008: a transaction of €168k, in MGI Pharma Inc. The clock since the last published purchase (8 August 2006) now reads 7,381 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David B. Sharrock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
6,000 shares@ US$41.00Common StockSEC:0001181431-08-005105:0
12,750 shares@ US$5.00Common Stock, par value $.01 per shareSEC:0001033025-07-000009:0
2,000 shares@ US$13.61Common StockSEC:0001181431-06-046356:0
Canonical exit: 6 Nov 2006 (T+90)
2,000 shares@ US$14.00Common StockSEC:0001181431-06-046356:1
Canonical exit: 6 Nov 2006 (T+90)
4 of 4 declarations
